C-JUN AND MULTISTAGE CARCINOGENESIS - ASSOCIATION OF OVEREXPRESSION OF INTRODUCED C-JUN WITH PROGRESSION TOWARD A NEOPLASTIC END-POINT IN MOUSE JB6 CELLS SENSITIVE TO TUMOR PROMOTER-INDUCED TRANSFORMATION
Rg. Watts et al., C-JUN AND MULTISTAGE CARCINOGENESIS - ASSOCIATION OF OVEREXPRESSION OF INTRODUCED C-JUN WITH PROGRESSION TOWARD A NEOPLASTIC END-POINT IN MOUSE JB6 CELLS SENSITIVE TO TUMOR PROMOTER-INDUCED TRANSFORMATION, Molecular carcinogenesis, 13(1), 1995, pp. 27-36
Tumor promoters such as 12-O-tetradecanoylphorbol-13-acetate (TPA) and
epidermal growth factor (ECF) induce neoplastic transformation, eleva
ted c-jun protein expression, and activator protein-1 (AP-l)-dependent
gene expression in JB6 mouse epidermal cells sensitive to tumor promo
ters (clone 415a Pc cells). In contrast, JB6 cells resistant to tumor
promoter-induced transformation (clone 307b P- cells) exhibit a greatl
y reduced IPA or EGF inducible c-jun expression and AP-1 activity. We
have recently shown that induced AP-1 is necessary for tumor promoter-
induced transformation of Pc cells because introduction of a dominant
negative c-jun mutant into Pc cells inhibits both AP-1 dependent trans
activation and the transformation response to tumor promoter. The inte
nt of the investigation presented here was to test the hypothesis that
elevation of AP-1 activity is sufficient to cause progression to the
Pc phenotype in P- cells or to the transformed phenotype in Pc cells.
Clonally derived Pc and P- recipient cells transfected with a human c-
jun expression construct and overexpressing c-jun protein were tested
for progression by assaying for constitutive or inducible anchorage in
dependent phenotype and nude-mouse tumorigenicity. Overexpression of c
-jun did not produce progression in P- cells but did increase the prob
ability of progression in Pc cells (two of five transfectant cell line
s progressed to the tumor phenotype). In addition, c-jun overexpressio
n did not increase AP-1 activity in any of the P-/-c-jun transfectants
or in the two of five P+/-c-jun transfectants that acquired the trans
formed phenotype. The P+/-c-jun transfectants that showed elevated AP-
1 activity did not progress to the tumor phenotype, demonstrating that
an increase in AP-1 activity is insufficient for this progression. Si
nce Pc-to-tumor phenotype progression occurred in cells overexpressing
c-jun but not AP-1, we propose that P+-to-transformed phenotype progr
ession is c-jun dependent and AP-1 independent. (C) 1995 Wiley-Liss, I
nc.